DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 173 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,188,000 | +121.0% | 58,619 | +50.4% | 0.34% | +54.3% |
| Q2 2020 | $990,000 | -21.8% | 38,983 | -43.4% | 0.22% | -44.3% |
| Q1 2020 | $1,266,000 | -66.4% | 68,915 | -59.7% | 0.39% | -52.6% |
| Q4 2019 | $3,769,000 | +889.2% | 171,088 | +379.6% | 0.83% | +704.9% |
| Q4 2018 | $381,000 | -47.2% | 35,673 | -24.6% | 0.10% | -3.7% |
| Q3 2018 | $722,000 | +24.7% | 47,286 | 0.0% | 0.11% | +17.6% |
| Q2 2018 | $579,000 | +28.1% | 47,286 | 0.0% | 0.09% | +21.3% |
| Q1 2018 | $452,000 | -22.2% | 47,286 | -26.5% | 0.08% | -27.9% |
| Q4 2017 | $581,000 | – | 64,340 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,080,237 | $103,638,000 | 10.86% |
| Aquilo Capital Management, LLC | 1,454,686 | $36,949,000 | 7.45% |
| RTW INVESTMENTS, LP | 7,152,918 | $181,684,000 | 5.11% |
| EcoR1 Capital, LLC | 2,721,993 | $69,139,000 | 5.11% |
| BRIDGER MANAGEMENT, LLC | 1,473,568 | $37,429,000 | 3.47% |
| DAFNA Capital Management LLC | 454,236 | $11,538,000 | 3.33% |
| Parkman Healthcare Partners LLC | 300,805 | $7,640,000 | 2.15% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $4,318,000 | 1.25% |
| Integral Health Asset Management, LLC | 110,000 | $2,794,000 | 0.84% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,013,087 | $25,732,000 | 0.63% |